Estimates from each trial were combined by the use of inverse variance-weighted averages of logarithmic HR in random-effects analysis
Both have real answers in the recent data, and the answers point in opposite directions depending on who you are and how fast youre dropping weight
BPC-157 operates through a distinct set of systems-level effects including modulation of nitric oxide signalling, growth-factor receptor expression, dopamine pathway markers, and angiogenic factor regulation
GLP-1 receptor agonists have been shown to reduce major adverse cardiovascular events including cardiovascular death, heart attack, and stroke in patients with type 2 diabetes
How BPC-157 May Work (Preclinical Evidence) Summary: BPC-157 (a 15-amino-acid peptide) shows multi-system activity in animal and in-vitro studies, including effects on angiogenesis, nitric-oxide (NO) signaling, gastro-mucosal integrity, tendon healing pathways, and endothelial function